5.24
1.55%
0.08
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
97.89%
0.1268
|
6.0022 | - | - | - |
Operating Expenses |
33.98%
5.6098
|
4.1871 | 3.5641 | 3.2543 | 2.9001 |
Benefits Costs and Expenses |
5.1788
|
- | - | - | - |
Costs And Expenses |
5.1788
|
- | - | - | - |
Operating Income/Loss |
402.07%
-5.483
|
1.8152 | -3.5641 | -3.2543 | -2.9001 |
Income/Loss From Continuing Operations Before Tax |
353.89%
-5.0519
|
1.9898 | -3.422 | -3.0954 | -2.7365 |
Income/Loss From Continuing Operations After Tax |
499.05%
-5.0519
|
1.266 | -3.422 | -3.0954 | -2.7365 |
Net Income/Loss
|
499.05%
-5.0519
|
1.266 | -3.422 | -3.0954 | -2.7365 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,878%
14.46
|
0.2905 | 9.9479 | 9.9479 | 9.7218 |
Diluted Average Shares |
4,878%
14.46
|
0.2905 | 9.9479 | 9.9479 | 9.7218 |
Basic Earnings Per Share |
333.33%
-0.35
|
0.15 | -0.34 | -0.31 | -0.28 |
Diluted Earnings Per Share |
333.33%
-0.35
|
0.15 | -0.34 | -0.31 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):